Andrew Avins to Prostatic Hyperplasia
This is a "connection" page, showing publications Andrew Avins has written about Prostatic Hyperplasia.
Connection Strength
1.655
-
What do I tell patients about saw palmetto for benign prostatic hyperplasia? Urol Clin North Am. 2011 Aug; 38(3):261-77.
Score: 0.389
-
A detailed safety assessment of a saw palmetto extract. Complement Ther Med. 2008 Jun; 16(3):147-54.
Score: 0.306
-
Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006 Feb 09; 354(6):557-66.
Score: 0.266
-
Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study. Contemp Clin Trials. 2005 Jun; 26(3):397-401.
Score: 0.250
-
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011 Sep 28; 306(12):1344-51.
Score: 0.098
-
Performance of the American Urological Association Symptom Index with and without an additional urge incontinence item. Urology. 2011 Sep; 78(3):550-4.
Score: 0.097
-
Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011 May; 185(5):1793-803.
Score: 0.095
-
Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials. 2009 Dec; 6(6):628-36.
Score: 0.087
-
Saw palmetto and lower urinary tract symptoms: what is the latest evidence? Curr Urol Rep. 2006 Jul; 7(4):260-5.
Score: 0.068